SCHEIBLER LUKAS

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$119,571.90
Insider Sells Quantity
12
Insider Sells Sum
$5.71M

Insider Activity of SCHEIBLER LUKAS

According to the SEC Form 4 filings, SCHEIBLER LUKAS, being in a position of

  1. Chief Research Officer at Apellis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10000 shares for $600,000,
    over all time since 2018-05-24, has bought 5870 shares for $119,572, and sold 113351 share for $5.71M.

The largest purchase of all time was on 2018-05-24 and amounted to 5870 shares of Apellis Pharmaceuticals, Inc. for $119,572.

The largest sale of all time was on 2022-04-01 and amounted to 22992 shares of Apellis Pharmaceuticals, Inc. for $1.27M.

Biography of SCHEIBLER LUKAS

No biography is available at this moment.

2023-12-01SaleApellis Pharmaceuticals, Inc.
APLS
Chief Research Officer
10,000
0.0084%
$60.00$600,000-27.18%
2023-09-06SaleApellis Pharmaceuticals, Inc.
APLS
Chief Research Officer
1,756
0.0015%
$43.01$75,526+12.12%
2022-05-27SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
10,000
0.0095%
$43.00$430,000+36.13%
2022-04-21SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
10,000
0.0079%
$43.00$430,000+3.91%
2022-04-05SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
1,218
0.0012%
$60.09$73,186-10.88%
2022-04-04SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
4,753
0.0044%
$57.18$271,788-9.55%
2022-04-01SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
22,992
0.0216%
$55.05$1.27M-4.05%
2022-02-11SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
3,332
0.0034%
$46.80$155,938+10.03%
2022-02-10SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
20,000
0.0216%
$50.00$1M+7.94%
2022-02-08SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
20,000
0.0202%
$45.00$900,000+12.09%
2022-01-31SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
2,466
0.0024%
$38.47$94,867+25.2%
2021-06-10SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
6,834
0.0083%
$60.00$410,040-26.33%
2018-05-24PurchaseApellis Pharmaceuticals, Inc.
APLS
See Remarks
5,870
0.0108%
$20.37$119,572-10.08%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.